Age and Comedications Influence Levetiracetam Pharmacokinetics in Children
- 31 October 2010
- journal article
- research article
- Published by Elsevier BV in Pediatric Neurology
- Vol. 43 (4), 231-235
- https://doi.org/10.1016/j.pediatrneurol.2010.05.008
Abstract
The pharmacokinetics of many antiepileptic drugs differs between adults and children. The influence of age and concomitant medications on the dose/concentration ratio of levetiracetam was examined in 103 children with epilepsy. Dosing and plasma levels of levetiracetam and concomitant antiepileptic drugs were reviewed retrospectively. The dose/concentration ratio was calculated as the weight-normalized dose (mg/kg/day) divided by the steady-state trough plasma drug level, which was used as a measure of apparent oral clearance of levetiracetam. Children were classified into age groups and treatment groups: levetiracetam given with enzyme inducers (n = 24) or nonenzyme inducers (n = 69), or as monotherapy (n = 10). Levetiracetam clearance differed significantly between age groups (0-4, 5-11, and 12-17 years), i.e., the younger the child, the higher the clearance. The increase was 1.7-fold between the youngest and oldest age groups. Children on enzyme inducers exhibited significantly higher clearance (1.3-fold), compared with those on nonenzyme inducers and monotherapy. Levetiracetam did not influence the clearance of lamotrigine, valproate, topiramate, or clonazepam. In conclusion, younger age and comedication with an enzyme inducer increased levetiracetam clearance. This finding should be taken into account when treating individual patients.Keywords
This publication has 19 references indexed in Scilit:
- Effect of Age and Comedication on Levetiracetam Pharmacokinetics and TolerabilityEpilepsia, 2007
- Pharmacokinetics of Levetiracetam in Infants and Young Children with EpilepsyEpilepsia, 2007
- Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproateEpilepsy Research, 2007
- Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizuresNeurology, 2006
- Clinical Pharmacokinetics of New-Generation Antiepileptic Drugs at the Extremes of AgeClinical Pharmacokinetics, 2006
- Levetiracetam Therapeutic Monitoring in Patients with EpilepsyTherapeutic Drug Monitoring, 2004
- Pharmacokinetic Study of Levetiracetam in ChildrenEpilepsia, 2001
- Levetiracetam for partial seizuresNeurology, 2000
- A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsySeizure, 2000
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000